Anti-mens APP/amyloïde beta Recombinant antilichaam (PMN310)

P05067

A4, ABPP, AD1, AICD-50, AICD-57, AICD-59, AID (50), AID (57), AID (59), APP, APPI, Abeta40, Abeta42, Alpha-CTF, Alpha-secretase C-terminal fragment, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid intracellular domain 50, Amyloid intracellular domain 57, Amyloid intracellular domain 59, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Amyloid-beta precursor protein, Amyloid-beta protein 40, Amyloid-beta protein 42, Beta-APP40, Beta-APP42, Beta-CTF, Beta-secretase C-terminal fragment, C31, C80, C83, C99, CVAP, Cerebral vascular amyloid peptide, Gamma-CTF (50), Gamma-CTF (57), Gamma-CTF (59), Gamma-secretase C-terminal fragment 50, Gamma-secretase C-terminal fragment 57, Gamma-secretase C-terminal fragment 59, N-APP, P3 (40), P3 (42), PN-II, PreA4, Protease nexin-II, S-APP-alpha, S-APP-beta, Soluble APP-alpha, Soluble APP-beta

ELISA, FACS, Functional assay

Protein A/G purified from cell culture supernatant.

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Please contact with the lab for this information.

>95% as determined by SDS-PAGE.

Liquid

ELISA: 1:2000-1:20000

For research use only

PMN310

Human

IgG1, kappa

0.01M PBS pH 7.4